Particularly, the expression of these anti-apoptotic proteins has been found to be higher in several cancer types; therefore, targeting the Bcl-2 family’s anti-apoptotic proteins may improve cancer therapy or serve to overcome tumor chemotherapy resistance [60]. This evidence concerns the gene BCL2 and neoplasm.